Clinical Comparison of Drug-Eluting Stents and Bare Metal Stents in Large Coronary Arteries |
Kim, Woo-Jong
(Division of Cardiology, Department of Internal Medicine, St. Carollo Hospital)
Cho, Jang-Hyun (Division of Cardiology, Department of Internal Medicine, St. Carollo Hospital) Jung, Jong-Heok (Division of Cardiology, Department of Internal Medicine, St. Carollo Hospital) Lee, Min-Kun (Division of Cardiology, Department of Internal Medicine, St. Carollo Hospital) Yoon, Jae-Sung (Division of Cardiology, Department of Internal Medicine, St. Carollo Hospital) Ahn, Young-Soo (Division of Cardiology, Department of Internal Medicine, St. Carollo Hospital) Hwang, Young-Jun (Division of Cardiology, Department of Internal Medicine, St. Carollo Hospital) Jung, Hong-Myung (Division of Cardiology, Department of Internal Medicine, St. Carollo Hospital) Kim, Su-Hyun (Division of Cardiology, Department of Internal Medicine, St. Carollo Hospital) Kim, Joon-Young (Division of Cardiology, Department of Internal Medicine, St. Carollo Hospital) Jeong, Myung-Ho (The Heart Center of Chonnam National University Hospital) |
1 | Steinberg DH, Mishra S, Javaid A, et al. Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (> or = 3.5 mm) coronary arteries. Am J Cardiol 2007;99: 599-602. DOI ScienceOn |
2 | Quizhpe AR, Feres F, de Ribamar Costa J Jr, et al. Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels. Am Heart J 2007;154:373-378. DOI ScienceOn |
3 | Joen DJ, Hong GR, Bae JH, et al. Immediate and follow-up results after long stent implantaton in diffuse long coronary lesions. Korean J Med 2000;58:48-57. |
4 | James SK, Stenestrand U, Lindback J, et al. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. N Engl J Med 2009;360:1933-1945. DOI ScienceOn |
5 | Kishore JH, Ricardo C, Pichard L. Clinical outcomes following drug-eluting versus bare metal stent implantation for lesion subsets excluded from pivotal clinical trials: finding from the GHOST Study (Guthrie Health System Off-Label StenT Study). J Interv Cardiol 2008;21:315-324. DOI ScienceOn |
6 | Koutouzis M, Nikolidakis S, Arealis G, Kyriakides ZS. Very late in-stent restenosis in a bare metal stent. Cardiology 2007;107: 360-361. DOI ScienceOn |
7 | Malenka DJ, Kaplan AV, Lucas FL, Sharp SM, Skinner JS. Outcomes Following Coronary Stenting in the era of bare-metal vs. the era of drug-eluting stents. JAMA 2008;299:2868-2876. DOI ScienceOn |
8 | Strozzi M, Anic D. Comparison of stent graft, sirolimus stent, and bare metal stent implanted in patients with acute coronary syndrome: clinical and angiographic follow-up. Croat Med J 2007;48:348-352. |
9 | Khattab AA, Otto A, Hochadel M, Toelg R, Geist V, Richardt G. Drug-eluting stents versus bare metal stents following rotational atherectomy for heavily calcified coronary lesions: late angiographic and clinical follow-up results. J Interv Cardiol 2007;20:100-106. DOI ScienceOn |
10 | Jensen J, Lagerqvist B, Aasa M, Sarev T, Nilsson T, Tornvall P. Clinical and angiographic follow-up after coronary drug-eluting and bare metal stent implantation: do drug-eluting stents hold the promise? J Intern Med 2006;260:118-124. DOI ScienceOn |
11 | Steinberg DH, Waksman R. Drug-eluting stent thrombosis vs bare metal stent restenosis: finding the lesser of two evils. Am Heart Hosp J 2007;5:151-154. DOI ScienceOn |
12 | Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356:989-997. DOI ScienceOn |
13 | Stone GW, Ellis SG, Cannon L, et al. Comparison of a polymerbased paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 2005;294:1215-1223. DOI ScienceOn |
14 | Fuchs AT, Kuehnl A, Pelisek J, et al. Meta-analysis shows similar risk of thrombosis after drug-eluting stent, bare-metal stent, or angioplasty. Endothelium 2008;15:93-100. DOI ScienceOn |
15 | Lee SH, Jeong MH, Hong YJ, et al. A long stent is the only predictive factor for coronary stent restenosis. Korean J Med 2001;60:529-536. |
16 | Barlis P, Kaplan S, Dimopoulos K, Ferrante G, Di Mario C. Comparison of bare-metal and sirolimus-or paclitaxel-eluting stents for aorto-ostial coronary disease. Cardiology 2008;111: 270-276. DOI ScienceOn |
17 | Tanigawa J, Sutaria N, Goktekin O, Di Mario C. Treatment of unprotected left main coronary artery stenosis in the drug-eluting stent era. J Interv Cardiol 2005;18:455-465. DOI ScienceOn |
18 | Tanzilli G, Pelliccia F, Pasceri V, et al. Randomized study on provisional stenting with sirolimus-eluting stent vs. bare metal stent for the treatment of true coronary bifurcations: the PROSUMER (PROvisional with sirolimus-eluting vs. bare metal stents in truE bifuRcations) study. Int J Cardiol 2011;146:240-241. DOI ScienceOn |
19 | Beohar N, Davidson CJ, Kip KE, et al. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA 2007;297:1992-2000. DOI ScienceOn |
20 | Ma X, Oyamada S, Gao F, et al. Paclitaxel/sirolimus combination coated drug-eluting stent: in vitro and in vivo drug release studies. J Pharm Biomed Anal 2011;54:807-811. DOI ScienceOn |
21 | Ho PM, Peterson ED, Wang L, et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA 2008;299:532-539. DOI ScienceOn |
22 | Zimarino M, Renda G, De Caterina R. Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents. Drugs 2005;65:725-732. DOI ScienceOn |
23 | Moohebati M, Falsoleiman H, Dehghani M, et al. Serum inflammatory and immune marker response after bare-metal or drug-eluting stent implantation following percutaneous coronary intervention. Angiology 2011;62:184-190. DOI ScienceOn |
24 | Alt E, Haehnel I, Beilharz C, et al. Inhibition of neointima formation after experimental coronary artery stenting: a new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost. Circulation 2000;101:1453-1458. DOI ScienceOn |
25 | Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-1029. DOI ScienceOn |
26 | Chechi T, Vittori G, Biondi Zoccai GG, et al. Single-center randomized evaluation of paclitaxel-eluting versus conventional stent in acute myocardial infarction (SELECTION). J Interv Cardiol 2007;20:282-291. DOI ScienceOn |
27 | De Felice F, Fiorilli R, Parma A, et al. Comparison of one-year cardiac events with drug-eluting versus bare metal stent implantation in rescue coronary angioplasty. Am J Cardiol 2011;107: 210-214. DOI ScienceOn |
28 | Seo YU, Koh YY, Kang MJ, Chang KS, Hong SP. Predictors of side branch occlusions just after coronary stenting. Korean J Med 2004;67:153-160. |
29 | Rossini R, Capodanno D, Lettieri C, et al. Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation. Am J Cardiol 2011;107:186-194. DOI ScienceOn |
30 | Lee SW, Lee SW, Hong MK, et al. Bail-out stenting for left main coronary artery dissection during catheter-based procedure: acute and long-term results. Korean J Med 2004;66:571-575. |
31 | Kaiser C, Galatius S, Erne P, et al. Drug-Eluting versus bare-metal stents in large coronary arteries. N Engl J Med 2010;363: 2310-2319. DOI |